American Trust Has $251,000 Position in The Cooper Companies, Inc. (NASDAQ:COO)

American Trust decreased its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 9.3% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,273 shares of the medical device company’s stock after selling 234 shares during the quarter. American Trust’s holdings in Cooper Companies were worth $251,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of COO. State Street Corp lifted its position in shares of Cooper Companies by 1.2% during the 3rd quarter. State Street Corp now owns 8,590,689 shares of the medical device company’s stock worth $947,897,000 after purchasing an additional 104,521 shares during the last quarter. Kayne Anderson Rudnick Investment Management LLC lifted its position in shares of Cooper Companies by 3.0% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 7,820,590 shares of the medical device company’s stock worth $682,738,000 after purchasing an additional 231,155 shares in the last quarter. Geode Capital Management LLC raised its holdings in Cooper Companies by 1.0% during the 3rd quarter. Geode Capital Management LLC now owns 4,796,556 shares of the medical device company’s stock worth $527,476,000 after purchasing an additional 48,559 shares during the last quarter. Victory Capital Management Inc. lifted its stake in shares of Cooper Companies by 23.0% in the 3rd quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock valued at $435,856,000 after purchasing an additional 737,726 shares during the period. Finally, Impax Asset Management Group plc boosted its stake in Cooper Companies by 31.0% during the 2nd quarter. Impax Asset Management Group plc now owns 2,359,798 shares of the medical device company’s stock worth $205,511,000 after acquiring an additional 558,886 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

COO has been the subject of a number of research reports. Citigroup lowered their target price on Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a report on Friday, December 6th. Piper Sandler upped their price objective on Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a report on Thursday, August 29th. StockNews.com cut Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday. Robert W. Baird upped their price target on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a report on Thursday, August 29th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Four analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat, Cooper Companies has an average rating of “Moderate Buy” and an average price target of $117.00.

Cooper Companies Price Performance

Shares of NASDAQ:COO opened at $94.85 on Friday. The company has a market capitalization of $18.93 billion, a P/E ratio of 48.64, a P/E/G ratio of 2.52 and a beta of 0.97. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The firm’s 50 day simple moving average is $103.49 and its two-hundred day simple moving average is $98.87. The Cooper Companies, Inc. has a 1-year low of $84.76 and a 1-year high of $112.38.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. The firm had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company’s quarterly revenue was up 9.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.87 EPS. Research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Insider Buying and Selling

In other Cooper Companies news, CEO Albert G. White III sold 114,992 shares of the firm’s stock in a transaction on Thursday, September 19th. The shares were sold at an average price of $110.53, for a total value of $12,710,065.76. Following the completion of the transaction, the chief executive officer now owns 165,273 shares of the company’s stock, valued at approximately $18,267,624.69. This trade represents a 41.03 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 2.00% of the stock is owned by insiders.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.